Brazil surveys QA and standards vs 05 regulations:
This article was originally published in Clinica
Executive Summary
Brazil has launched a survey of all local healthcare vigilance agencies to assess whether quality assurance regulations affecting 19,000 pathology, cytology and other laboratories, across both the public and private sectors, are effective. National regulatory agency Anvisa also hopes to assess how well these have upgraded their facilities in line with standards set in 2005 legislation (internal resolution RDC 302/2005) implementing the "technical regulation for the operation of clinical laboratories".
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.